Diazoxide
From Wikipedia, the free encyclopedia
Diazoxide
|
|
Systematic (IUPAC) name | |
7-chloro-3-methyl-4H-1,2,4-benzothiadiazine 1,1-dioxide | |
Identifiers | |
CAS number | |
ATC code | C02 V03AH01 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C8H7ClN2O2S |
Mol. mass | 230.672 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Protein binding | 90% |
Metabolism | Hepatic oxidation and sulfate conjugation |
Half life | 21-45 hours |
Excretion | Renal |
Therapeutic considerations | |
Pregnancy cat. | |
Legal status | |
Routes | Oral, intravenous |
Diazoxide is a potassium channel activator, which causes local relaxation in smooth muscle by increasing membrane permeability to potassium ions. This switches off voltage-gated calcium ion channels which inhibits the generation of an action potential.
It is used as a vasodilator in the treatment of acute hypertension, and also to decrease the secretion of insulin in disease states such as insulinoma (a tumor producing insulin).
|